Objectives To evaluate the use, effectiveness and safety of tyrosine kinase inhibitors (TKIs)
for chronic myelogenous leukaemia (CML) in clinical practice. Methods A retrospective …

Fast identification of BCR-ABL fusion genes is critical for precise diagnosis, risk stratification
and therapy scheme selection in leukemia. More convenient methods are needed for quickly …

Leucemia Mieloide Crônica de Crianças e Adolescentes Page 1 1 Maio/2021 Nº 622 Leucemia
Mieloide Crônica de Crianças e Adolescentes Page 2 2 MINISTÉRIO DA SAÚDE SECRETARIA …

The current aim for CML disease management in the TKI era is to provide age-and
sexmatched normal life duration to CML patients. Despite the excellent outcome, many …

Chronic myeloid leukemia (CML) is a hematologic malignancy, in which more than 95% of
CML patients are discovered with the Philadelphia chromosome (Ph) or BCR-ABL …

3. Staib L., Birebent B., Somasundaram R., Purev E., Braumuller H., Leeser C., Kuttner N., Li
W., Zhu D., Diao J., Wunner W., Speicher D., Beger HG., Song H. and Herlyn …

English Chronic Myeloid Leukemia (CML) is a very rare pathology accounting for 2-3% of
leukemias in children under 15-year old. Evidence-based guidelines for treatment of CML …

Chronic Myeloid Leukemia (CML) is a very rare pathology accounting for 2-3% of leukemias
in children under 15-year old. Evidence-based guidelines for treatment of CML have been …

Cancer is a lethal disease. Silent in the beginning, cancer will grow and expand its area,
possibly invading and spreading into other tissues. Current treatment methods are …

La CML è una patologia mieloproliferativa risultante dall'espansione policlonale di cellule
staminali Il trattamento d'elezione è imatinib (IM). Nonostante il successo di IM nel giro di 18 …